Anti-schizophrenia drug Cobenfy could treat Alzheimer's
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, USA, on Wednesday, December 27, 2023.…
Eisai Co Ltd
Biogen (BIIB) Third Quarter 2024 Earnings
A test tube is seen in front of the Biogen logo in this illustration taken on December 1, 2021. Ruvic…
Eisai Biogen's Leqembi Alzheimer's drug shows benefits over three years
The newly FDA-approved Alzheimer's treatment, Leqembi, will be prepared at Abington Neurological Associates in Abington, Pennsylvania on Tuesday, November 7,…
Novo Nordisk's liraglutide GLP-1 may slow the progression of Alzheimer's
A box of the drug Victoza, manufactured by Novo Nordisk Pharmaceutical, sits on a pharmacy counter in Provo, Utah, January…
Biogen Eisai's Leqembi Alzheimer's drug rejected by EU regulator
European drug regulators on Friday rejected Leqembi's Alzheimer's treatment Biogen and Eisaicreating another hurdle for companies as they struggle to…
Biogen (BIIB) Earnings Q1 2024
A test tube is seen in front of the Biogen logo in this illustration taken on December 1, 2021. Ruvic…
FDA approval of Eli Lilly's Alzheimer's drug delayed
Eli Lilly headquarters in Indianapolis, Indiana, U.S., on Wednesday, May 3, 2023. Shares of Eli Lilly & Co. rose in…
Alzheimer's drug Leqembi launched, nausea Apple Vision Pro
Good afternoon! The launch of the closely watched Alzheimer's drug Leqembi is off to a slow start. Even so, the…
What Eli Lilly Investors Can Learn from the Slow Launch of a Rival Drug
Club holding company Eli Lilly hopes to win approval for its Alzheimer's treatment in the coming weeks, but investors looking…
Biogen (BIIB) earnings in the fourth quarter of 2023
biogen on Tuesday reported fourth-quarter revenue and profit that fell from a year ago as it booked charges related to…